NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Vinod Patel
University of Warwick - Coventry / United Kingdom
Others
AD Scientific Index ID: 1258115
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Vinod Patel's MOST POPULAR ARTICLES
1-)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyBM Brenner, ME Cooper, D De Zeeuw, WF Keane, WE Mitch, HH Parving, ...New England journal of medicine 345 (12), 861-869, 200188512001
2-)
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo …HM Colhoun, DJ Betteridge, PN Durrington, GA Hitman, HAW Neil, ...The Lancet 364 (9435), 685-696, 200451512004
3-)
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a …AC GroupThe Lancet 370 (9590), 829-840, 200730842007
4-)
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trialsN Chaturvedi, M Porta, R Klein, T Orchard, J Fuller, HH Parving, R Bilous, ...The Lancet 372 (9647), 1394-1402, 20085422008
5-)
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trialAK Sjølie, R Klein, M Porta, T Orchard, J Fuller, HH Parving, R Bilous, ...The Lancet 372 (9647), 1385-1393, 20085392008
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept